SCHEMBL2211566

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2215584	0.90	GCK (0.61)	GCKNPC1RAB9ASMN1; SMN2PKM
	SCHEMBL2642681	0.90	GCK (0.60)	GCK
	SCHEMBL2215422	0.89	GCK (0.61)	GCKNPC1RAB9ASMN1; SMN2PKM
	SCHEMBL2642911	0.89	GCK (0.75)	GCKNPC1RAB9ASMN1; SMN2TP53
	SCHEMBL2211355	0.87	GCK (0.59)	GCKL3MBTL1
	SCHEMBL2213370	0.86	GCK (0.73)	GCKNPC1RAB9ASMN1; SMN2L3MBTL1
	SCHEMBL2212557	0.86	GCK (0.73)	GCKNPC1RAB9ASMN1; SMN2L3MBTL1
	SCHEMBL2208913	0.86	GCK (0.62)	GCKNPC1RAB9ASMN1; SMN2L3MBTL1
	SCHEMBL2642513	0.86	GCK (0.57)	GCK
	SCHEMBL2213086	0.85	GCK (0.58)	GCKL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.